Is Amrize Ltd (AMRZ) overvalued? · P/E 26, rev $11.81B
Amrize Ltd (AMRZ) is a building materials company listed on NYSE.
This page asks whether Amrize Ltd (AMRZ) looks expensive on cached numbers — not a short thesis.
Latest reported AMRZ revenue for 2025-12-31 was $11.81B. Net income was $1.19B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. AMRZ currently screens at market cap $30.35B and trailing P/E 26.2.
AMRZ currently screens at market cap $30.35B and trailing P/E 26.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AMRZ 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AMRZ stock page for the full model, not this heading.
Not investment advice.